Sangamo Therapeutics
SGMO
#10631
Rank
C$43.34 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-88.63%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$34.55 Million. In 2025 the company made an earning of -C$0.16 Billion a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.16 Billion-0.2%
2025 -C$0.16 Billion9.71%
2024 -C$0.14 Billion-17.27%
2023 -C$0.17 Billion-40.88%
2022 -C$0.29 Billion9.79%
2021 -C$0.26 Billion41.52%
2020 -C$0.19 Billion23.17%
2019 -C$0.15 Billion36.33%
2018 -C$0.11 Billion36.89%
2017 -C$79.69 Million-22.32%
2016 -C$0.11 Billion54.86%
2015 -C$66.25 Million75.62%
2014 -C$37.73 Million0.13%
2013 -C$37.68 Million
2011 -C$50.65 Million43.66%
2010 -C$35.26 Million28.52%
2009 -C$27.44 Million-23.55%
2008 -C$35.89 Million2.45%
2007 -C$35.03 Million19.5%
2006 -C$29.31 Million50.78%
2005 -C$19.44 Million75%
2004 -C$11.11 Million-33.25%
2003 -C$16.65 Million-62.27%
2002 -C$44.11 Million102.82%
2001 -C$21.75 Million23.21%
2000 -C$17.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.73 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.84 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.29 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$3.58 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$15.16 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.59 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.22 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA